Dr. Wayne A. Solley, MD

Dr. Solley practices at Texas Retina Associates in Arlington, Texas.

Dr. Solley's NPI, 1528042447, was assigned on December 5, 2005. Dr. Solley graduated from Carver College of Medicine in 1993. Dr. Solley holds Texas license K7398.

Dr. Solley's primary practice is Texas Retina Associates, at 801 W Randol Mill Rd, Arlington, TX 76012 in Tarrant County. The practice phone is (817) 261-9625.

Dr. Solley's primary practice is Texas Retina Associates in Arlington, Texas. Dr. Solley is also affiliated with Texas Health Arlington Memorial Hospital. Dmand AI also links Dr. Solley to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Solley practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Solley's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Solley is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Solley's licenses on file in 2 states: Texas and Georgia.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, dry eye, glaucoma, hereditary corneal conditions, hypertensive retinopathy and inflammation of iris among the conditions Dr. Solley treats.

CMS data shows 50,589 Medicare services from Dr. Solley across 22 procedure codes in 2024, for 1,177 Medicare patients. Medicare paid $4,395,757 for them.

CMS counts 1,177 Medicare patients who saw Dr. Solley in 2024. The largest group is 75 to 84, with 441 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Solley's median patient age at 74, with 55% women.

In 2024, Dr. Solley wrote 959 Medicare Part D claims for 382 patients. 63% of them were for generic drugs. CMS names the drug for 874 of them, across 12 drugs with 11 or more claims each, at $26,781 in total drug cost. In 2023, CMS named 852 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Solley for performance year 2024, reported as part of a group. Dr. Solley accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Solley in 2011. The most frequent topics are Fundus Oculi and Visual Acuity. Dr. Solley has published most often in Ophthalmology. Dr. Solley's most frequent co-authors are Mark Blumenkranz, MD, David G. Callanan, MD and David Jay Parks, MD.

Dmand AI links Dr. Solley to 1 clinical trial. Conditions studied include Diabetic Retinopathy and Diabetic Angiopathies.

CMS Open Payments shows 155 general payments to Dr. Solley from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $24,718.

Dmand AI lists 2 awards for Dr. Solley, most recently AAO Fellow in 2013.

Dr. Solley graduated from Carver College of Medicine in 1993. Dr. Solley is a member of AAO.

Dr. Solley is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.